Journal
CANCER LETTERS
Volume 336, Issue 2, Pages 347-358Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2013.03.025
Keywords
Guggulsterone; NF kappa B; Ras; Shh; Glioblastoma
Categories
Funding
- Department of Biotechnology (DBT, Government of India) [BT/PR/12924/Med/30/235/2009]
- Council of Scientific and Industrial Research (CSIR, Government of India)
Ask authors/readers for more resources
Since Shh pathway effector, Gli1, is overexpressed in gliomas, we investigated the effect of novel Shh inhibitor SANT-1 on glioma cell viability. Though SANT-I failed to induce apoptosis, it reduced proliferation of glioma stem-like cells. Apart from canonical Shh cascade, Gli1 is also induced by non-canonical pathways including NF kappa B. Therefore, a combinatorial strategy with Ras/NF kappa B inhibitor, Guggulsterone, was employed to enhance effectiveness of SANT-1. Guggulsterone inhibited Ras and NF kappa B activity and sensitized cells to SANT-1 induced apoptosis via intrinsic apoptotic mechanism. Inhibition of either Ras or NF kappa B activity was sufficient to sensitize cells to SANT-1. Guggulsterone induced ERK activation also contributed to Caspase-9 activation. Since SANT-1 and Guggulsterone differentially target stem-like and non-stem glioma cells respectively, this combination warrants investigation as an effective anti-glioma therapy. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available